FDA approval

Update: 2d Circuit denies split in Church & Dwight and Apotex rulings

By Andre Hanson (US) on December 19, 2016

On December 2, 2016, the United States Court of Appeals for the Second Circuit denied rehearing by the Panel and rehearing en banc. On December 5, 2016, the Court withdrew its previous opinion, which was to have been published…

Second Circuit may address apparent Apotex/Church & Dwight split

By Robert Rouder (US), Saul Perloff (US) & Andre Hanson (US) on November 2, 2016

In our September 28, 2016 blog post, and subsequent Law360 Article, we reported that an internal Second-Circuit split had arisen regarding the deference owed to allegedly false and misleading pharmaceutical/medical device advertising where the FDA had considered and approved…

Intra-Circuit split should give advertisers pause

By Robert Rouder (US), Saul Perloff (US) & Andre Hanson (US) on September 28, 2016

While advertising off-label claims for medical devices and pharmaceuticals may be like sailing into stormy waters, companies might assume that advertising their products based on FDA-vetted labeling is, if not a safe harbor, at least a reasonably sheltered cove. The…

The Brand Protection Blog

FDA approval

Update: 2d Circuit denies split in Church & Dwight and Apotex rulings

Second Circuit may address apparent Apotex/Church & Dwight split

Intra-Circuit split should give advertisers pause

About

Topics

Archives